Sonim Technologies (SONM) Q4 2025 earnings summary

Executive summary

• Completed acquisition of a cryptocurrency trading platform and rebranded as DNA X, Inc., shifting focus from mobile devices to crypto trading.

• Sold mobile device assets for $15 million, using proceeds to repay debt and support the new trading business.

• Leadership changes included CEO resignation and appointment of a new board member with crypto expertise.

Financial highlights

• No revenue from continuing operations in Q4 2025; all prior revenue classified under discontinued operations.

• General & administrative expenses for continuing operations were $1.2 million in Q4 2025, mainly due to legal and transaction costs.

• Ended 2025 with $1.3 million in cash from continuing operations.

• Net loss from continuing operations was $7.96 million for 2025, with a total net loss of $20.66 million including discontinued operations.

• Stockholders' deficit increased to $7.96 million at year-end 2025.

Outlook and guidance

• Anticipates future growth in revenue, gross margin, and profitability as the trading platform exits testing and begins public marketing.

• Plans to enhance the platform and expand the number of tradable cryptocurrencies to drive growth and margins.